Active Cases Database

Ex-1042 Lex Machina statistics comparing final written decisions

DECISION Settlement Prior to Institution of Trial 37 C.F.R. § 42.74

Joint Motion to Terminate

Joint Motion to Terminate

Authorized Response to Director Review Request

DECISION Settlement Prior to Institution of Trial 37 C.F.R. § 42.74

Authorized Response to Director Review Request

Final Written Decision Determining All Challenged Claims Unpatentable (Paper 33) in Imperative Care, Inc. v. Inari Medical, Inc., IPR2025-00156 (P.T.A.B. Apr. 7, 2026)

Joint Motion to Terminate

2021-01-22 [01] '484 Petition for Inter Partes Review [IPR2021-00453]

Ex. 2001 Settlement Agreement

Motion to Withdraw Petition for Inter Partes Review

Patent Owner's Preliminary Response to Petition for Inter Partes Review

Joint Request that Settlement Agreement Filed Separately as Exhibit 1300 be Kept Separate from the Files

Joint Motion to Terminate

Patent Owner's Preliminary Response to Petition for Inter Partes Review

JOINT REQUEST TO TREAT SETTLEMENT AGREEMENT AS BUSINESS CONFIDENTIAL INFORMATION

Email, Subject_IPR2025-01486 and IPR2025-01488 Director Review Requests.pdf

Ex. 2007 2025.07.27 Final Written Decision Procedures for AIA Trial Proceedings

Unopposed Motion to Withdraw Petition and Terminate Inter Partes Review

JOINT REQUEST TO TREAT SETTLEMENT AGREEMENT AS BUSINESS CONFIDENTIAL INFORMATION

Joint Motion to Treat Settlement Agreement As Business Confidential Information

Authorized Response to Director Review Request

Joint Request to Keep Settlement Agreement as Business Confidential Information

Joint Motion to Terminate Proceeding as to Petitioner Hisense USA Corporation

Joint Request to Treat Settlement Agreement as Business Confidential Information

Patent Owner's Request for Director Review to Vacate Institution and Terminate Inter Partes Review

Petitioner’s Request for Director Review of the Notice of Discretionary Denial

Foundation Medicine, Inc. v. Guardant Health, Inc., IPR2019- 00652, Paper 12 – Decision Granting Institution of Inter Partes Review (Corrected)

JOINT REQUEST TO TREAT SETTLEMENT AGREEMENT AS BUSINESS CONFIDENTIAL INFORMATION

Order Denying Director Review of Institution Decision

2019-04-10 [01] '533 Petition for Inter Partes Review [IPR2019-00916]

Order: Settlement as to Harbor Freight Tools USA Inc. and MWE Investments, LLC 35 U.S.C. sec. 317; 37 C.F.R. secs. 42.72, 42.74

A Study of Unpatentability Findings in Inter Partes Review (IPR) Final Written Decisions (FWDs), United States Patent and Trademark Office, Nov. 21, 2024

Authorized Response to Director Review Request

Ex. 1011 - 2021-01-22 [01] '484 Petition for Inter Partes Review [IPR2021-0

Ex. 1005 - 2019-04-10 [01] '533 Petition for Inter Partes Review [IPR2019-0

Guardant Health, Inc. v. University of Washington, IPR2022- 00816, Paper 3 – Petition for Inter Partes Review of U.S. Patent No. 10,760,127 (Corrected)

Twinstrand Biosciences, Inc. v. Guardant Health, Inc., IPR2022-01400, Paper 2 – Petition for Inter Partes Review of U.S. Patent No. 11,149,306 (Corrected)

2021-01-22 [01] '484 Petition for Inter Partes Review [IPR2021-00453]

Twinstrand Biosciences, Inc. v. Guardant Health, Inc., IPR2022-01400, Paper 2 – Petition for Inter Partes Review of U.S. Patent No. 11,149,306 (Corrected)

Guardant Health, Inc. v. University of Washington, IPR2022- 00450, Paper 3 – Petition for Inter Partes Review of U.S. Patent No. 10,689,699 (Corrected)

Termination Decision: Settlement Prior to Institution of Trial 37 C.F.R. sec. 42.74

Joint Motion to Terminate Prior to Institution

Joint Request to Treat the Parties' Settlement Agreement as Business Confidential Information

Termination Decision: Settlement Prior to Institution of Trial 37 C.F.R. sec. 42.74

DECISION Settlement Prior to Institution of Trial Granting Joint Request to Treat Settlement Agreement as Business Confidential Information 37 C.F.R. § 42.74

Joint Request to Treat the Parties' Settlement Agreement as Business Confidential Information

A Study of Unpatentability Findings in Inter Partes Review (IPR) Final Written Decisions (FWDs), United States Patent and Trademark Office, Nov. 21, 2024

Guardant Health, Inc. v. University of Washington, IPR2022- 00935, Paper 2 – Petition for Inter Partes Review of U.S. Patent No. 10,287,631 (Corrected)